Work

P34 RKER-065, a novel ActRII ligand trap, counteracted the negative impact of glucocorticoid treatment on bone and muscle

Year: 2023

Type: conference-abstract

Source: Neuromuscular Disorders

DOI: 10.1016/j.nmd.2023.07.161

Authors: G. Zhen, R. Nathan, M. Cahill, C. Materna, F. Fisher, L. Lerner, J. Lachey, J. Seehra

Institution: Keros Therapeutics (United States)

Language: English

Topic: Muscle Physiology and Disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387307163

Cites:

Cited by:

Related to: 10